Literature DB >> 9402118

Prospective randomized comparative study of bipolar electrocoagulation versus heater probe for treatment of chronically bleeding internal hemorrhoids.

D M Jensen1, R Jutabha, G A Machicado, M E Jensen, S Cheng, J Gornbein, K Hirabayashi, G Ohning, G Randall.   

Abstract

BACKGROUND: Our purpose was to compare the efficacy, complications, failure rates, and crossovers of heater and bipolar probe treatments of chronically bleeding internal hemorrhoids.
METHODS: Eighty-one patients (31 female, 50 male) with mean age of 53 years had large (grade 2 to 3) internal hemorrhoids with bleeding for a mean of 12 years, had failed medical management, and were randomized in a prospective study of anoscopic treatments to heater versus bipolar probes. Failure was defined as a major complication or failure to reduce the size of all internal hemorrhoids with three or more treatments.
RESULTS: With similar background variables and no difference in treatment times, rectal bleeding and other symptoms were controlled in a shorter time with the heater probe than with the bipolar probe (77 versus 121 days). Five complications (fissures, bleeding, or rectal spasm) occurred with the bipolar probe, and two occurred with the heater probe. The heater probe caused more pain during treatments but had significantly fewer failures and crossovers.
CONCLUSIONS: For patients who had failed medical management of chronically bleeding internal hemorrhoids, the techniques and complications of heater and bipolar probes were similar, but pain was more common, failures and crossovers were less frequent, and the time to symptom relief was shorter with the heater probe than with the bipolar probe.

Entities:  

Mesh:

Year:  1997        PMID: 9402118     DOI: 10.1016/s0016-5107(97)70037-3

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  9 in total

1.  Endoscopic Management of Lower Gastrointestinal Bleeding.

Authors:  Naveen Arya; Norman E. Marcon
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

Review 2.  Diagnosis and management of lower gastrointestinal bleeding.

Authors:  Jürgen Barnert; Helmut Messmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

Review 3.  The Evaluation and Office Management of Hemorrhoids for the Gastroenterologist.

Authors:  Mitchel Guttenplan
Journal:  Curr Gastroenterol Rep       Date:  2017-07

4.  Morphine spinal block anesthesia in patients who undergo an open hemorrhoidectomy: a prospective analysis of pain control and postoperative complications.

Authors:  Hélio Moreira; José Pt Moreira; Raniere R Isaac; Onofre Alves-Neto; Thiago Ac Moreira; Tiago Hm Vieira; Andressa Ms Brasil
Journal:  Ann Coloproctol       Date:  2014-06-23

5.  Portuguese Society of Gastroenterology Consensus on the Diagnosis and Management of Hemorrhoidal Disease.

Authors:  Paulo Salgueiro; Ana Célia Caetano; Ana Maria Oliveira; Bruno Rosa; Miguel Mascarenhas-Saraiva; Paula Ministro; Pedro Amaro; Rogério Godinho; Rosa Coelho; Rúben Gaio; Samuel Fernandes; Vítor Fernandes; Fernando Castro-Poças
Journal:  GE Port J Gastroenterol       Date:  2019-09-05

Review 6.  Rethinking What We Know About Hemorrhoids.

Authors:  Robert S Sandler; Anne F Peery
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-27       Impact factor: 11.382

7.  Interventional treatments for prolapsing haemorrhoids: network meta-analysis.

Authors:  J Z Jin; S Bhat; K-T Lee; W Xia; A G Hill
Journal:  BJS Open       Date:  2021-09-06

8.  Initial experience of radiofrequency ablation for the treatment of advanced haemorrhoidal disease.

Authors:  Jignesh Ashwin Gandhi; Pravin Hanumant Shinde; Amay Banker; Sadashiv N Chaudhari
Journal:  Prz Gastroenterol       Date:  2021-10-14

9.  Randomized prospective study of endoscopic rubber band ligation compared with bipolar coagulation for chronically bleeding internal hemorrhoids.

Authors:  Rome Jutabha; Dennis M Jensen; Disaya Chavalitdhamrong
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.